Cargando…
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
BACKGROUND: There is an urgent need for highly efficacious antiviral therapies in immunosuppressed hosts who develop coronavirus disease (COVID-19), with special concern for those affected by hematological malignancies. CASE PRESENTATION: Here, we report the case of a 75-year-old male with chronic l...
Autores principales: | Guisado-Vasco, P., Carralón-González, M. M., Aguareles-Gorines, J., Martí-Ballesteros, E. M., Sánchez-Manzano, M. D., Carnevali-Ruiz, D., García-Coca, M., Barrena-Puertas, R., de Viedma, R. García, Luque-Pinilla, J. M., Sotres-Fernandez, G., Fernández-Sousa, J. M., Luepke-Estefan, X. E., López-Martín, J. A., Jimeno, J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743692/ https://www.ncbi.nlm.nih.gov/pubmed/35012608 http://dx.doi.org/10.1186/s13045-021-01220-0 |
Ejemplares similares
-
Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy
por: Guisado-Vasco, P., et al.
Publicado: (2021) -
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
por: Varona, Jose F, et al.
Publicado: (2022) -
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
por: Varona, Jose F., et al.
Publicado: (2023) -
Plitidepsin for multiple myeloma
Publicado: (2019) -
Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)